Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-164OV for prevention of COPD exacerbations
ACTRN12610000916044Phase 2Completed
- Sponsor
- Hunter Immunology
- Start
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inactivated non-typeable haemophilus influenzae in chronic obstructive pulmonary disease (COPD), sponsored by Hunter Immunology. Started Jan 2011; status: completed.
02
Drugs
inactivated non-typeable haemophilus influenzae
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ACTRN12610000916044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000916044.